Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06396598 · ClinicalTrials.gov registry record · NA
Electronic Symptom Monitoring Program for Triggered Palliative Referrals in Patients With Thoracic Cancer
A NA study of Malignant Thoracic Neoplasm, sponsored by Ohio State University Comprehensive Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 157
- Enrollment target
- 1
- Study location
NCT06396598: Recruiting NA study of Malignant Thoracic Neoplasm, sponsored by Ohio State University Comprehensive Cancer Center.
NCT06396598 is a NA study of Malignant Thoracic Neoplasm that is actively recruiting participants, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 157 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06396598, a NA study of Malignant Thoracic Neoplasm, is actively recruiting participants, sponsored by Ohio State University Comprehensive Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 157 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial evaluates earlier symptom management through remote electronic symptom monitoring (such as through an app on patient's phone), and accessibility of palliative care self-referral by patients with thoracic cancer and caregivers by proxy (legal representative). Thoracic cancer occurs in the chest and often causes symptoms for patients. Patients and/or their caregivers are often unable to attend in-person clinic visits for various reasons. The most frequently reported symptom by patients at initial palliative care consultations is pain, and caregivers' most common concerns are pain management for the patient, stress reduction, and fears about patient decline. Earlier palliative care referral can help control these symptoms before they worsen, providing a better quality of life for patients and caregivers. improve physical and emotional functioning for patients and caregivers in cancer care. This study may help researchers learn how an electronic symptom monitoring program may provide an earlier and more accessible way for patients with thoracic cancer to receive palliative care.
Conditions Studied
Interventions
- OTHER Survey Administration
- OTHER Electronic Health Record Review
- OTHER Media Intervention
- OTHER Internet-Based Intervention
- OTHER Educational Activity
Study Locations (1)
Ohio
- Ohio State University Comprehensive Cancer Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 157 participants |
| Start Date | 2024-02-09 |
| Est. Completion | 2026-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06396598
The ClinicalTrials.gov registry entry for NCT06396598 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 157 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Malignant Thoracic Neoplasm appearing as the primary indexed condition, and to 5 interventions - of which Survey Administration is the first listed.
NCT06396598 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT06396598 about?
NCT06396598 is a clinical study titled "Electronic Symptom Monitoring Program for Triggered Palliative Referrals in Patients With Thoracic Cancer". This clinical trial evaluates earlier symptom management through remote electronic symptom monitoring (such as through an app on patient's phone), and accessibility of palliative care self-referral by patients with thoracic cancer and caregivers by proxy (legal representative). Thoracic cancer occur...
What is the current status of trial NCT06396598?
This trial is currently recruiting. It is a NA study. The enrollment target is 157 participants. The study started on 2024-02-09. Estimated completion is 2026-02-28.
What conditions does trial NCT06396598 study?
This clinical trial studies the following conditions: Malignant Thoracic Neoplasm.
What interventions are being tested in trial NCT06396598?
The interventions under investigation include: Survey Administration (OTHER), Electronic Health Record Review (OTHER), Media Intervention (OTHER), Internet-Based Intervention (OTHER), Educational Activity (OTHER).
Who is sponsoring clinical trial NCT06396598?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06396598 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00022646 · 157 participants · Phase 2
Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- NCT00062465 · 157 participants · Phase 2
Treating Rheumatoid Arthritis With Tripterygium Wilfordi Hook F or Sulfasalazine
- NCT00127933 · 157 participants · Phase 4
XeNA Study - A Study of Xeloda (Capecitabine) in Patients With Invasive Breast Cancer
- NCT00257907 · 157 participants
Immune Response to Mycobacterium Tuberculosis Infection
Similar registry start date
- NCT05684068 · started 2028-08 · NA
Dimensional Changes: Randomized Clinical Trial
- NCT07167953 · started 2028-08 · NA
The Spiral MRI Study
- NCT07215013 · started 2028-07 · NA
Acoustic Resonance Therapy for Treating Empty Nose Syndrome
- NCT07443332 · started 2028-07 · NA
Culturally Adapted Contingency Management
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.